cidara therapeutics

cidara therapeutics

NASDAQ:CDTX

Chart

Detailed Quote

Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and prevention of diseases. The company's Rezafungin is a novel molecule in the echinocandin class of antifungals. It is developing rezafungin for the first-line treatment and prevention of serious, invasive fungal infections which are associated with high mortality rates.
Featured Articles and Interviews
Two vials labelled "H5N1 Vaccine." One stands and one lays on its side behind the first.

Bird Flu Vaccine Stocks: 8 Companies Developing H5N1 Vaccines

Press Releases

Cidara Therapeutics Reaches Target Enrollment of Phase 3 ANCHOR Trial Evaluating CD388 for Prevention of Seasonal Influenza in High-Risk Populations

Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results

Cidara Therapeutics to Participate in November Investor Conferences

The Conversation (0)